AXL and head and neck squamous cell carcinoma: Similar as our results, AXL was markedly related to higher pathological grade and shorter progression-free survival in head and neck squamous cell carcinoma (HNSCC) and its overexpression could increase the resistance of HNSCC to radiotherapy, chemotherapy and cetuximab [14].